Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Widener, Nancy
ASTER, NCT05171049 / 2021-003076-14: A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE	Recruiting	3	1655	Europe, Canada, Japan, US, RoW	Abelacimab, MAA868, Apixaban, Eliquis	Anthos Therapeutics, Inc., Itreas	Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism	12/26	02/27
MAGNOLIA, NCT05171075 / 2021-003085-12: A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE	Recruiting	3	1020	Europe, Canada, US, RoW	Abelacimab, MAA868, Dalteparin, Fragmin	Anthos Therapeutics, Inc., Itreas	Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism	12/26	02/27